(PharmaNewsWire.Com, January 20, 2018 ) The Asia-Pacific Blood Testing Market was worth $9.5 billion in 2016 and estimated to be growing at a CAGR of 3.35%, to reach $11.21 billion by 2021. During the forthcoming years, Asia-Pacific has been recognized as the fastest growing region.
Blood is a vital component of the body and is used routinely in a wide range of hospital procedures. Every year millions of units of blood are donated globally and used in necessary transplantation, cancer therapies, and accident victims and for patients undergoing other forms of surgeries.
Key factors contributing to the growth of this market contain growing number of chronic cases and high price of treatment, rise in occurrence of infectious diseases, speedily increasing aging population, boost in product approvals and launches, increase in demand for quick diagnostic techniques, and high commonness of bloodstream infections. Still, factor such as lack of technically skilled professionals is restraining the growth of this market.
The Asia-Pacific blood testing market is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase. Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Based on geography the Asia-Pacific market is analysed under various countries China, India, Japan, South Korea and Australia. China and India are the fastest growing market in the Asia-Pacific region. Major players in this market are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMιrieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
Market Segmentation 1) By Type Complete Blood Count Red Blood Cells White Blood Cells Haemoglobin Hematocrit Platelets Blood Chemistry Tests Test for Electrolytes Blood Glucose Calcium Test for Kidney Function Blood Enzyme Tests Troponin Creatine Kinase Blood Clotting Tests Prothrombin time Activated Partial Thromboplastin time Blood Coagulation 2) By Diseases Anaemia Infection Leukaemia Hypokalemia Kidney Disorders Heart Attack Coronary Heart Disease 3) By Methods Manual Blood Culture Testing Automated Blood Culture Testing Automated Blood Culture System Blood Culture Instruments
Reasons to buy Asia-Pacific for Blood Testing Market Research Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
